Author:
Wang Hao,Zhang Hengxiang,Chen Yuhan,Wang Huina,Tian Yangzi,Yi Xiuli,Shi Qiong,Zhao Tao,Zhang Baolu,Gao Tianwen,Guo Sen,Li Chunying,Guo Weinan
Abstract
Melanoma is the most lethal form of skin cancer, resulting from the malignant transformation of epidermal melanocytes. Recent revolutionary progress in targeted therapy and immunotherapy has prominently improved the treatment outcome, but the survival of melanoma patients remains suboptimal. Ferroptosis is greatly involved in cancer pathogenesis and can execute the outcome of immunotherapy. However, the detailed regulatory mechanisms of melanoma cell ferroptosis remain elusive. Herein, we report that Wnt/β-catenin signaling regulates ferroptosis and melanoma immunotherapy efficacy via the regulation of MITF. First of all, we found that Wnt/β-catenin signaling was prominently suppressed in melanoma cell ferroptosis. Then, we proved that targeting β-catenin exacerbated melanoma cell ferroptosis by promoting the generation of lipid peroxidation both in vitro and in vivo. Subsequent mechanistic studies revealed that MITF mediated the effect of Wnt/β-catenin signaling on melanoma cell ferroptosis, and PGC1α and SCD1 were documented as two main effectors downstream of Wnt/β-catenin-MITF pathway. Ultimately, pharmacological inhibition of β-catenin or MITF increased the efficacy of anti-PD-1 immunotherapy in preclinical xenograft tumor model by promoting ferroptosis. Taken together, Wnt/β-catenin signaling deficiency exacerbates ferroptosis in melanoma via the regulation of MITF. Targeting Wnt/β-catenin-MITF pathway could be a promising strategy to potentiate ferroptosis and increase the efficacy of anti-PD-1 immunotherapy.
Funder
National Natural Science Foundation of China
Support Program of Young Talents in Shaanxi Province
Reference55 articles.
1. Recent Advances in the Treatment of Melanoma;N. Engl. J. Med.,2021
2. The melanoma revolution: From UV carcinogenesis to a new era in therapeutics;Science,2014
3. Acquired resistance to cancer immunotherapy;Semin. Immunopathol.,2019
4. A Review of the Molecular Pathways Involved in Resistance to BRAF Inhibitors in Patients with Advanced-Stage Melanoma;Med. Sci. Monit. Int. Med. J. Exp. Clin. Res.,2020
5. Cancer Statistics, 2021;CA Cancer J. Clin.,2021
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献